GOLBON STERBIS: Open Payments
NPI 1033595178 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,476 in 43 payments from 11 companies in 2025. Trend: 2023 $51,712 · 2024 $22,480 · 2025 $18,476
Speaker / faculty: $10,162Consulting: $3,563Travel & lodging: $2,755Food & beverage: $1,768Education: $228
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 17 | $10,956 |
| PFIZER INC. | 6 | $6,154 |
| BeiGene USA, Inc. | 3 | $504 |
| Lilly USA, LLC | 3 | $215 |
| Janssen Biotech, Inc. | 5 | $214 |
| Alnylam Pharmaceuticals Inc. | 4 | $136 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: BRUKINSA, ADCETRIS, AMVUTTRA, RYLAZE, OJJAARA, DARZALEX, TALVEY, CARVYKTI.
Industry payments across MI — which companies pay providers there.
